ReviewThe Journal of clinical investigation2026

Expanding the therapeutic scope of PARP inhibitors in breast cancer: current indications and future directions.

Charlotte S Walmsley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.